世界の結核ワクチン治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04904)
◆英語タイトル:Global Tuberculosis Vaccine Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04904
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは結核ワクチン治療の世界市場について調査・分析した資料です。種類別(免疫療法ワクチン、ブースターワクチン、その他)の市場規模、用途別(病院、診療所、研究所、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別結核ワクチン治療の競争状況、市場シェア
・世界の結核ワクチン治療市場:種類別市場規模 2015年-2020年(免疫療法ワクチン、ブースターワクチン、その他)
・世界の結核ワクチン治療市場:種類別市場規模予測 2021年-2026年(免疫療法ワクチン、ブースターワクチン、その他)
・世界の結核ワクチン治療市場:用途別市場規模 2015年-2020年(病院、診療所、研究所、その他)
・世界の結核ワクチン治療市場:用途別市場規模予測 2021年-2026年(病院、診療所、研究所、その他)
・北米の結核ワクチン治療市場分析:米国、カナダ
・ヨーロッパの結核ワクチン治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの結核ワクチン治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の結核ワクチン治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの結核ワクチン治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Sanofi、Merck、Serum Institute of India、GlaxoSmithKline、Japan BCG Lab、IDT Biologics、GreenSignal Bio Pharma、Taj Pharmaceuticals、Bavarian Nordic、China National Biotec Group
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
America holds the largest market share of TB vaccines due to the major market players are concentrated and its emphasis on vaccination against TB.

Market Analysis and Insights: Global Tuberculosis Vaccine Treatment Market
The global Tuberculosis Vaccine Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Tuberculosis Vaccine Treatment Scope and Market Size
Tuberculosis Vaccine Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Vaccine Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group

Market segment by Type, the product can be split into
Immunotherapeutic Vaccines
Booster Vaccines
Others
Market segment by Application, split into
Hospitals
Clinics
Research Institutes
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tuberculosis Vaccine Treatment Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunotherapeutic Vaccines
1.4.3 Booster Vaccines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Tuberculosis Vaccine Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Tuberculosis Vaccine Treatment Market Perspective (2015-2026)
2.2 Global Tuberculosis Vaccine Treatment Growth Trends by Regions
2.2.1 Tuberculosis Vaccine Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tuberculosis Vaccine Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Tuberculosis Vaccine Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tuberculosis Vaccine Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Tuberculosis Vaccine Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Vaccine Treatment Players by Market Size
3.1.1 Global Top Tuberculosis Vaccine Treatment Players by Revenue (2015-2020)
3.1.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tuberculosis Vaccine Treatment Market Concentration Ratio
3.2.1 Global Tuberculosis Vaccine Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Vaccine Treatment Revenue in 2019
3.3 Tuberculosis Vaccine Treatment Key Players Head office and Area Served
3.4 Key Players Tuberculosis Vaccine Treatment Product Solution and Service
3.5 Date of Enter into Tuberculosis Vaccine Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Vaccine Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tuberculosis Vaccine Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
5.2 Global Tuberculosis Vaccine Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Tuberculosis Vaccine Treatment Market Size (2015-2020)
6.2 Tuberculosis Vaccine Treatment Key Players in North America (2019-2020)
6.3 North America Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
6.4 North America Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Tuberculosis Vaccine Treatment Market Size (2015-2020)
7.2 Tuberculosis Vaccine Treatment Key Players in Europe (2019-2020)
7.3 Europe Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
7.4 Europe Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

8 China
8.1 China Tuberculosis Vaccine Treatment Market Size (2015-2020)
8.2 Tuberculosis Vaccine Treatment Key Players in China (2019-2020)
8.3 China Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
8.4 China Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Tuberculosis Vaccine Treatment Market Size (2015-2020)
9.2 Tuberculosis Vaccine Treatment Key Players in Japan (2019-2020)
9.3 Japan Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
9.4 Japan Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Tuberculosis Vaccine Treatment Market Size (2015-2020)
10.2 Tuberculosis Vaccine Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

11 India
11.1 India Tuberculosis Vaccine Treatment Market Size (2015-2020)
11.2 Tuberculosis Vaccine Treatment Key Players in India (2019-2020)
11.3 India Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
11.4 India Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Tuberculosis Vaccine Treatment Market Size (2015-2020)
12.2 Tuberculosis Vaccine Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
12.4 Central & South America Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Tuberculosis Vaccine Treatment Introduction
13.1.4 Sanofi Revenue in Tuberculosis Vaccine Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Tuberculosis Vaccine Treatment Introduction
13.2.4 Merck Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Details
13.3.2 Serum Institute of India Business Overview
13.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Introduction
13.3.4 Serum Institute of India Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.3.5 Serum Institute of India Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Tuberculosis Vaccine Treatment Introduction
13.4.4 GlaxoSmithKline Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Japan BCG Lab
13.5.1 Japan BCG Lab Company Details
13.5.2 Japan BCG Lab Business Overview
13.5.3 Japan BCG Lab Tuberculosis Vaccine Treatment Introduction
13.5.4 Japan BCG Lab Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.5.5 Japan BCG Lab Recent Development
13.6 IDT Biologics
13.6.1 IDT Biologics Company Details
13.6.2 IDT Biologics Business Overview
13.6.3 IDT Biologics Tuberculosis Vaccine Treatment Introduction
13.6.4 IDT Biologics Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.6.5 IDT Biologics Recent Development
13.7 GreenSignal Bio Pharma
13.7.1 GreenSignal Bio Pharma Company Details
13.7.2 GreenSignal Bio Pharma Business Overview
13.7.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Introduction
13.7.4 GreenSignal Bio Pharma Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.7.5 GreenSignal Bio Pharma Recent Development
13.8 Taj Pharmaceuticals
13.8.1 Taj Pharmaceuticals Company Details
13.8.2 Taj Pharmaceuticals Business Overview
13.8.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Introduction
13.8.4 Taj Pharmaceuticals Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.8.5 Taj Pharmaceuticals Recent Development
13.9 Bavarian Nordic
13.9.1 Bavarian Nordic Company Details
13.9.2 Bavarian Nordic Business Overview
13.9.3 Bavarian Nordic Tuberculosis Vaccine Treatment Introduction
13.9.4 Bavarian Nordic Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.9.5 Bavarian Nordic Recent Development
13.10 China National Biotec Group
13.10.1 China National Biotec Group Company Details
13.10.2 China National Biotec Group Business Overview
13.10.3 China National Biotec Group Tuberculosis Vaccine Treatment Introduction
13.10.4 China National Biotec Group Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.10.5 China National Biotec Group Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Sanofi、Merck、Serum Institute of India、GlaxoSmithKline、Japan BCG Lab、IDT Biologics、GreenSignal Bio Pharma、Taj Pharmaceuticals、Bavarian Nordic、China National Biotec Group

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の結核ワクチン治療市場2026:インサイト・予測(Global Tuberculosis Vaccine Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。